The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer’s Disease

Figure 1

The workflow for analysis of differentially expressed genes (DEGs) and finding out the pathogenesis of learning and memory impairment, new biomarkers, potential therapeutic targets, and drugs for AD.